Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis

Patrizia Vici, Anna Di Benedetto, Cristiana Ercolani, Laura Pizzuti, Luigi Di Lauro, Domenico Sergi, Francesca Sperati, Irene Terrenato, Rosanna Dattilo, Claudio Botti, Alessandra Fabi, Maria Teresa Ramieri, Lucia Mentuccia, Camilla Marinelli, Laura Iezzi, Teresa Gamucci, Clara Natoli, Ilio Vitale, Maddalena Barba, Marcella MottoleseRuggero De Maria, Marcello Maugeri-Saccà

Research output: Contribution to journalArticle

Abstract

Response of cancer cells to chemotherapy-induced DNA damage is regulated by the ATM-Chk2 and ATR-Chk1 pathways. We investigated the association between phosphorylated H2AX (f-H2AX), a marker of DNA double-strand breaks that trigger the ATM-Chk2 cascade, and phosphorylated Chk1 (pChk1), with pathological complete response (pCR) in triple-negative breast cancer (TNBC) patients treated with neoadjuvant chemotherapy. f-H2AX and pChk1 were retrospectively assessed by immunohistochemistry in a series of pretreatment biopsies related to 66 patients. In fifty-three tumors hormone receptor status was negative in both the diagnostic biopsies and residual cancers, whereas in 13 cases there was a slight hormone receptor expression that changed after chemotherapy. Internal validation was carried out. In the entire cohort elevated levels of f-H2AX, but not pChk1, were associated with reduced pCR rate (p = 0.009). The association tested significant in both uni- and multivariate logistic regression models (OR 4.51, 95% CI: 1.39-14.66, p = 0.012, and OR 5.07, 95% CI: 1.28-20.09, p = 0.021, respectively). Internal validation supported the predictive value of the model. The predictive ability of f-H2AX was further confirmed in the multivariate model after exclusion of tumors that underwent changes in hormone receptor status during chemotherapy (OR 7.07, 95% CI: 1.39-36.02, p = 0.018). Finally, in residual diseases a significant decrease of f-H2AX levels was observed (p <0.001). Overall, f-H2AX showed ability to predict pCR in TNBC and deserves larger, prospective studies.

Original languageEnglish
Pages (from-to)42773-42780
Number of pages8
JournalOncotarget
Volume6
Issue number40
DOIs
Publication statusPublished - 2015

Keywords

  • DNA damage and repair
  • Pathological complete response
  • Triple-negative breast cancer

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis'. Together they form a unique fingerprint.

  • Cite this

    Vici, P., Di Benedetto, A., Ercolani, C., Pizzuti, L., Di Lauro, L., Sergi, D., Sperati, F., Terrenato, I., Dattilo, R., Botti, C., Fabi, A., Ramieri, M. T., Mentuccia, L., Marinelli, C., Iezzi, L., Gamucci, T., Natoli, C., Vitale, I., Barba, M., ... Maugeri-Saccà, M. (2015). Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis. Oncotarget, 6(40), 42773-42780. https://doi.org/10.18632/oncotarget.6001